ClinicalTrials.Veeva

Menu

Splenic Hilar Nodes in Splenic Flexure Cancer

U

University of Rome Tor Vergata

Status

Unknown

Conditions

Metastases, Lymphatic
Colon Cancer

Treatments

Other: Review of records and follow up

Study type

Observational

Funder types

Other

Identifiers

NCT04666883
REGISTROSPERIMENTAZIONI/21

Details and patient eligibility

About

Report the incidence of metastases to the splenic hilar lymphnodes from splenic flexure primaries. This mode of spread has not been previously characterized for these tumours.

Enrollment

20 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All splenic flexure cancer patients

Exclusion criteria

  • No consent to data utilization

Trial design

20 participants in 1 patient group

Splenic flexure cancer patients
Description:
Splenic flexure cancer patients
Treatment:
Other: Review of records and follow up

Trial contacts and locations

1

Loading...

Central trial contact

Bruno Sensi, MD; Giuseppe S Sica, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems